Tanvex BioPharma
$0.000000
1
+$0.00+0% Monday 00:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.68
-1.48
-1.29
-1.1
Expected EPS
-1.51692086304
Actual EPS
N/A
Financials
-371.8%Profit Margin
Unprofitable12.93MRevenue
-48.06MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.
Show more...
CEO
Country
Cayman Islands
ISIN
KYG8676P1037
Listings
0 Comments
Share your thoughts
FAQ
What is Tanvex BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Tanvex BioPharma stocks are traded under the ticker TANVF.
When is the next Tanvex BioPharma earnings date?▼
Tanvex BioPharma is going to release the next earnings report on November 16, 2026.
What is Tanvex BioPharma revenue for the last year?▼
Tanvex BioPharma revenue for the last year amounts to 12.93M USD.
What is Tanvex BioPharma net income for the last year?▼
TANVF net income for the last year is -48.06M USD.
In which sector is Tanvex BioPharma located?▼
Tanvex BioPharma operates in the Other sector.
When did Tanvex BioPharma complete a stock split?▼
Tanvex BioPharma has not had any recent stock splits.